Investing.com - Shares of CombiMatrix Corp (NASDAQ:CBMX) rallied on Tuesday and were up about 40% on the home stretch to the closing bell with investors cheering a proposed merger of the company with ...

IRVINE, Calif., April 7, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics laboratory offering genetic array testing, a comprehensive profiling of chromosomes and ...

IRVINE, Calif., April 11, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has entered into a strategic partnership with Clarient, Inc., a GE Healthcare Company, ...

CombiMatrix Corp (NASDAQ: CBMX), a molecular diagnostics company, announced on Thursday it has begun to explore strategic alternatives, including potential M&A activity and business development ...

Earlier this afternoon CombiMatrix issued financial results for the 2017 first quarter. If you've not received this news release or would be like to be added to the company's email distribution list, ...

CombiMatrix Corp., a biotechnology company, is going to move its corporate headquarters to Irvine from a Seattle suburb. It said in a Securities and Exchange Commission filing that it will close its ...

Invitae has agreed to acquire two diagnostics developers, CombiMatrix and Good Start Genetics, for a combined $72 million in cash and stock, in a deal designed to expand the buyer’s diagnostics ...

To significantly cut operating costs CEO to step down as part of restructuring Co to begin search for new CEO April 19 (Reuters) - Biotechnology firm CombiMatrix Corp said its chief executive officer ...

Acacia Research Corporation has announced that its CombiMatrix group’s subsidiary, CombiMatrix Molecular Diagnostics (CMDX), has entered into a partnership with The Centre for Applied Genomics (TCAG) ...

CombiMatrix has appointed a new CEO. Occupying that position will be Mark McDonough, currently the chief commercial officer of the firm. He replaces the retiring R. Judd Jessup, and will formally take ...

CombiMatrix Corporation (NASDAQ:CBMX) announced today that it has received a four year contract for $858,298 from NASA’s Ames Research Center to design and test a microfluidic system that incorporates ...

Mukilteo-based CombiMatrix, a life-sciences technology company, plans to fully spin off from parent company Acacia Research, according to a filing Tuesday with the Securities and Exchange Commission.